Additionally, CHEK2-Associated Hereditary Cancer Syndrome [105, 108] and cancer predisposition associated with BRIP1 mutations [50, 68, 81] may represent conditions with a potential association with MM risk. This evidence concerns the gene CHEK2 and Miyoshi myopathy.